Article Details
Retrieved on: 2022-11-28 19:22:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
According to a U.K. trial, Eliquis (apixaban), widely prescribed for COVID-19, did not help patients recovering from moderate and severe COVID.
Article found on: www.msn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here